a public good project by the
Synthesis
Company
of California

© 2026

Paul Pfeffer | doi.page

0 works0 citations0 h-index

Paul Pfeffer

Queen Mary University of London(GB)Barts Health NHS Trust(GB)

Publications by Year

Research Areas

Asthma and respiratory diseases, Chronic Obstructive Pulmonary Disease (COPD) Research, Respiratory and Cough-Related Research, Long-Term Effects of COVID-19, Inhalation and Respiratory Drug Delivery

Most-Cited Works

→ Air pollution and its effects on the immune system(2020)696 cited
→ Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study(2021)642 cited
→ Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study(2022)414 cited
→ Characterization of Severe Asthma Worldwide(2019)316 cited
→ Eosinophilic and Noneosinophilic Asthma(2021)253 cited
→ Distinct endotypes of steroid-resistant asthma characterized by IL-17Ahigh and IFN-γhigh immunophenotypes: Potential benefits of calcitriol(2015)180 cited

→ Deep Sequencing of B Cell Receptor Repertoires From COVID-19 Patients Reveals Strong Convergent Immune Signatures(2020)

151 cited

→ Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic era(2020)150 cited

→ Defining a Severe Asthma Super-Responder: Findings from a Delphi Process(2021)139 cited

→ The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease(2021)129 cited